What is the prognosis of mold-related allergic bronchopulmonary aspergillosis (ABPA) and allergic bronchopulmonary mycosis (ABPM)?

Updated: Dec 02, 2020
  • Author: Shih-Wen Huang, MD; Chief Editor: Harumi Jyonouchi, MD  more...
  • Print

According to a Northwestern University follow-up study, if patients' conditions are properly diagnosed and treated, especially with a systemic corticosteroid, most should not progress beyond stage IV clinical disease. [31, 32] However, once patients enter stage V (fibrosis), the condition is almost irreversible. Those patients may also develop emphysema, cor pulmonale, and right heart failure. Early and aggressive treatment with a corticosteroid is critical in preventing advancement of the disease. Whether adding an antifungal agent improves the prognosis is debatable.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!